AI Market & Investment

Per-minute AI generation costs fell from hundreds of dollars to single digits, enabling enterprise deployment across marketing, drug discovery, and manufacturing. Rezolve AI projects $500M annual recurring revenue by 2026 as teams of 10 now handle work previously requiring 50-100 people. Copyright issues and training data licensing remain barriers to adoption.

Large language model expansion into regional markets is colliding with heightened regulatory scrutiny as safety concerns mount. Google's medical AI advice now carries buried warnings, while antimicrobial-resistant infections kill 4 million annually—a figure driving investor attention to AI-powered diagnostics. The convergence of governance pressure and market growth is reshaping corporate deployment timelines.